AF-3485 program (Angelini Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAF-3485 program (Angelini Pharmaceuticals)
Drug Alias NamemPGES-1 inhibitors (Angelini)AF-3485
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin E synthase inhibitors
TargetsProstaglandin E synthase
Therapy Area/IndicationsPainInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAngelini Pharma SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAngelini Pharma SPA
Active IndicationsN/A
Inactive IndicationsPainInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A